YU31302A - Flaster za produženo lečenje bubuljica i postupak dobijanja - Google Patents

Flaster za produženo lečenje bubuljica i postupak dobijanja

Info

Publication number
YU31302A
YU31302A YU31302A YUP31302A YU31302A YU 31302 A YU31302 A YU 31302A YU 31302 A YU31302 A YU 31302A YU P31302 A YUP31302 A YU P31302A YU 31302 A YU31302 A YU 31302A
Authority
YU
Yugoslavia
Prior art keywords
ackne
band aid
components
manufacturing
agent
Prior art date
Application number
YU31302A
Other languages
English (en)
Inventor
Spiros Fotinos
Original Assignee
Lavipharm S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from YU58998A external-priority patent/YU58998A/sh
Application filed by Lavipharm S.A. filed Critical Lavipharm S.A.
Publication of YU31302A publication Critical patent/YU31302A/sh

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Flaster za produženo davanje sredstava protiv bubuljičavosti na jednom izabranom mestu koja obuhvata jedan noseći sloj, jednu oblogu za ispuštanje i više od jednog matričnog sloja, pri čemu se taj više od jednog matričnog sloja koristi kao nosač, ili povezan sa nekim nosačem za sredstva protiv bubuljičavosti, s tim što taj flaster sadrži najmanje dva sredstva pogodna za lečenje bubuljičavosti, pri čemu ta najmanje dva sredstva sadrže delotvorne količine najmanje dva aktivna sastojka iz najmanje dve različite grupe aktivnih sastojaka, i što su pomenute najmanje dve različite grupe birane iz grupe koja obuhvata keratolitičke agense, sredstva protiv nadraživanja, antiseptička sredstva, sredstva protiv mikroskopskih organizama, hormone, hormonske agoniste, hormonske antagoniste i druge agense pogodne za lečenje bubuljičavosti.[Band aid for prolonged administration of anti ackne agent on one picked out spot includes one base layer, one release coating and more than one matrix layer, where that more than one matrix layer is used as a support, or is coupled with some support for antiackne agent, where that band aid contains at least two components appropriate for healing acknes, where those at least two components comprise effective quantities of at least two active components from at least two different groups of active components, and that the mentioned are at least two different groups picked up from group that includes keratolytic agents, agents against microscopic organisms, hormones, hormone agonists, hormone antagonists and other agents suitable for the treatment of ackne.
YU31302A 1996-06-20 2002-04-24 Flaster za produženo lečenje bubuljica i postupak dobijanja YU31302A (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GR96100207 1996-06-20
YU58998A YU58998A (sh) 1996-06-20 1998-12-18 Naprava za lokalno lečenje bubuljica i postupak za njenu izradu
YU31302 2002-04-24

Publications (1)

Publication Number Publication Date
YU31302A true YU31302A (sh) 2004-12-31

Family

ID=47722727

Family Applications (1)

Application Number Title Priority Date Filing Date
YU31302A YU31302A (sh) 1996-06-20 2002-04-24 Flaster za produženo lečenje bubuljica i postupak dobijanja

Country Status (1)

Country Link
YU (1) YU31302A (sh)

Similar Documents

Publication Publication Date Title
NO985938L (no) Anordning for topikal behandling av akne og fremgangsmÕte ved fremstilling derav
EP0850651A3 (en) Method of applying drug-release coatings
ES2004395A6 (es) Procedimiento de obtencion de un sistema de vehiculo disolvente de doble fase, para compuestos farmaceuticamente activos.
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
CA2257976A1 (en) Compositions and methods for coating medical devices
CA2277824A1 (en) Dosage composition for nasal delivery and method of use of the same
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
NZ336462A (en) Pharmaceutical composition of fenofibrate with high biological availability
CA2279842A1 (en) Method and apparatus for the coating of substrates for pharmaceutical use
CA2125148A1 (en) A Carbohydrate Glass Matrix for the Sustained Release of a Therapeutic Agent
BR9506305A (pt) Aparelho e processo para preparação de formas sólidas com desprendimento controlado do ingrediente ativo
DK462585A (da) Diffusionsovertrukket polydepotpraeparat
ATE186211T1 (de) Verfahren zu herstellung einer manteltablette mit spitzem kern
ATE164769T1 (de) Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
MY113965A (en) Intravaginal delivery system
GR3005399T3 (sh)
EP0988850A3 (en) An oral active agent delivery system
NZ298994A (en) Drug dosage form containing a core having at least two layers, both containing a polymer that forms microscopic gel beads upon hydration but only one contains the drug and an impermeable, insoluble coating containing apertures which provide for the hydration and release of the beads
CA2303339A1 (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
ES2157731A1 (es) Preparacion farmaceutica oral de un compuesto de anticidad antifungica y procedimiento para su preparacion.
AR020542A1 (es) UN MATERIAL HIDROSOLUBLE O DISPERSABLE EN AGUA, UN MÉTODO PARA DEPOSITAR UN AGENTE DE BENEFICIO SOBRE UN SUSTRATO USANDO DICHO MATERIAL Y UNA COMPOSICIoN QUE COMPRENDE A DICHO MATERIAL.
CA2198535A1 (en) Method of increasing testosterone
CA2085871A1 (en) A controlled release drug dispersion delivery device
CA2271944A1 (en) Formulation for electrically assisted delivery of lidocaine and epinephrine
HK1063017A1 (en) Microgranules based on active principle and methodfor making same